Cargando…
Do schistosome vaccine trials in mice have an intrinsic flaw that generates spurious protection data?
The laboratory mouse has been widely used to test the efficacy of schistosome vaccines and a long list of candidates has emerged from this work, many of them abundant internal proteins. These antigens do not have an additive effect when co-administered, or delivered as SWAP homogenate, a quarter of...
Autores principales: | Wilson, R. Alan, Li, Xiao-Hong, Castro-Borges, William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4756456/ https://www.ncbi.nlm.nih.gov/pubmed/26888413 http://dx.doi.org/10.1186/s13071-016-1369-9 |
Ejemplares similares
-
Schistosome Feeding and Regurgitation
por: Skelly, Patrick J., et al.
Publicado: (2014) -
Models of Protective Immunity against Schistosomes: Implications for Vaccine Development
por: Wilson, R Alan
Publicado: (2023) -
Enzymatic Shaving of the Tegument Surface of Live Schistosomes for Proteomic Analysis: A Rational Approach to Select Vaccine Candidates
por: Castro-Borges, William, et al.
Publicado: (2011) -
The Schistosome Oesophageal Gland: Initiator of Blood Processing
por: Li, Xiao-Hong, et al.
Publicado: (2013) -
Schistosome Syntenin Partially Protects Vaccinated Mice against Schistosoma mansoni Infection
por: Figueiredo, Barbara C., et al.
Publicado: (2014)